Sharepoint Solutions
PRODUCTS
-
We provide science-first solutions for challenging molecules, specializing in particle engineering, bioavailability, and GMP manufacturing across Bend, OR; Clearwater, FL; and Gainesville, GA.
-
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
-
Get faster process insights and dynamic control of substrate feeding without the loss of bioreactor or fermenter volume.
Keep Your Cells Happy
Fluctuations in glucose levels, associated with infrequent measurements and bolus feeding, may cause metabolic deregulation and undesirable process deviations.
That’s where MAVEN comes in. It has your back, automatically monitoring and controlling glucose and lactate concentrations, helping you realize your PAT strategy.
-
Guide operators through dynamic workflows from equipment startup to maintenance.
-
New and Unused BAUSCH Advanced Technology Group (BATG) vial filling line.
WHITE PAPERS AND CASE STUDIES
-
FDA's Regenerative Medicine Advanced Therapy (RMAT) Program
RMAT qualification requires preliminary clinical evidence demonstrating the potential to address an unmet medical need. This designation grants benefits like intensive guidance and faster FDA review.
-
Partnering For Precision In An IPF Study: Securing Timely Deliverables And Key Endpoints
A pharmaceutical company enlisted Worldwide Clinical Trials to help achieve on-time results for their Phase IIa IPF clinical trial, enabling them to manage vendors and meet challenging deadlines.
-
Annex 1: Sterile Fill/Finish For Early Phase Clinical Supplies
Meeting stringent requirements for sterile fill/finish operations hinges on robust contamination control strategies, advanced isolator technology, and rigorous integrity testing to ensure patient safety.
-
Impact Of Immunogenicity On Efficacy And Safety Of Biosimilars
The presence of ADAs can affect the effectiveness and safety of biologic drugs. Read why regulatory agencies emphasize the need for extensive immunogenicity evaluation in biosimilar development.
-
Richter BioLogics Drives Efficiency And Compliance With Unified Quality
Learn how one CDMO tripled production, improved audit readiness, and built customer trust by unifying quality systems and embracing a digital-first approach.
-
Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.
-
Performance Dashboards Development
Learn about a biotech company's successful implementation of a two-level KPI dashboard system. This enhanced performance monitoring, aligned departmental goals, and strengthened team communication.
-
Flexible Integrations To Reduce Risks And Increase Efficiencies
Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
NuGenesis 9.3 – What's New
Explore the latest features of a user-centric lab management system that comprises data, workflow, and sample management capabilities to support the entire product lifecycle.
-
A Risk-Based Approach To Plasmid DNA And mRNA Process Development
Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.
-
Improving Patient Health and Safety: Quality and Analytical Scientist
Explore how an analytical scientist enhanced quality and compliance for a pharmaceutical company by managing complex analytical testing and vendor interactions.
-
Navigating The Complexities Of Pre-Filled Syringe Manufacturing
Drawing on our extensive expertise in sterile injectables (SI), here, we highlight practical strategies and proven solutions designed to help navigate challenges and support the reliable, scalable production of high-quality PFS therapies for patients worldwide.
NEWS
-
The Secret Life Of Catalysts: New Discoveries In Chemical Reactions1/24/2025
Scientists from the Interface Science Department of the Fritz Haber Institute of the Max Planck Society in collaboration with beamline scientists at the Helmholtz-Zentrum Berlin have made an advancement in the field of electrocatalysis.
-
Study To Determine Most Effective PFAS Treatments For High-Risk Homes3/2/2026
Research to fill key knowledge gaps on the effectiveness of household water treatment systems for PFAS and other fluorinated organic compounds is under way under the direction of Assistant Professor Dr. Riley Mulhern of the University of Colorado Boulder.
-
Merck To Acquire US Biopharma Company SpringWorks Therapeutics To Accelerate Sustainable Growth Of Healthcare Business4/28/2025
Merck, a leading science and technology company, and SpringWorks Therapeutics, Inc., a Stamford, Connecticut-based commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced the companies have entered into a definitive agreement for Merck to acquire SpringWorks.
-
MapleTech Introduces Aspire Quick Start2/10/2026
Maple Technologies (MapleTech), developer of the Aspire suite, a platform of integrated modules for processing personal and commercial Property & Casualty insurance, announces the availability of Quick Start, a step-by-step workflow embedded in the Aspire underwriting platform that automates trucking insurance risk intake.
-
Securing Water Systems Against Cyber-Threats: Idaho Leads With Cyber-Informed Engineering3/6/2025
When it comes to cybersecurity research, the Idaho National Laboratory (INL) and Idaho have a relationship that dates back to the 1990s and was hallmarked in 2019 with the opening of the state-funded Cybercore Integration Center on INL’s Research and Education Campus in Idaho Falls.